The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- Celgene reported second quarter earnings this morning, and although revenues beat estimates, earnings fell short; the company had EPS of $0.82 while analysts expected $1.06. … Continue Reading
Read now- In a press release this morning Genetic Technologies (NASDAQ:GENE) announced that California has cleared the company’s breast cancer DNA test BrevaGenâ„¢ for sale into the … Continue Reading
Read now- Covidien (NYSE:COV) reported strong fiscal 3rd quarter results, with sales of $3 billion in-line with expectations. Importantly, margins and net income beat expectations and the … Continue Reading
Read now- Rumors percolated today – pushing QCOR down nearly $9/share – that a conference call to be hosted by a Broker-Dealer would feature an expert discussing … Continue Reading
Read now- In a post-market announcement last night, Novavax (NASDAQ:NVAX) said they have delayed trials of their influenza vaccine until 2013 after the FDA denied fast-track status … Continue Reading
Read now- This morning, Idenix Pharmaceuticals (NASDAQ:IDIX) announced that the FDA has granted Fast-Track status to their development-stage hepatitis C (HCV) treatment IDX719. The drug is an … Continue Reading
Read nowLong Ideas - Nuvo Research Inc. announced that the U.S. Patent and Trade Office (PTO) reinstated a patent protecting the company’s Synera Patch through July 2020. Synera is … Continue Reading
Read now
